Lancashire and South Cumbria
Formulary
Formulary
14 Immunological products and vaccines
This chapter does not contain details of vaccines that are otherwise listed in ‘Immunisation against infectious disease’ (the “Green Book”). Please consult this reference for details of vaccines and related products. |
14-05 Normal immunoglobulin
| Human normal immunoglobulin |
|
Formulary
|
Therapeutic immunoglobulin is recommended to be available as a routinely commissioned treatment option for the indications within the criteria set out in the NHSE Clinical Commissioning Policy for the use of therapeutic immunoglobulin (Ig) England (2024). The stand-alone policy for the use of human normal immunoglobulin for preventative treatment of idiopathic Systemic Capillary Leak Syndrome following an acute episode (adults) will be available until the NHS England Clinical Commissioning Policy for the use of therapeutic immunoglobulin (Ig) in England, is updated to include this indication. |
 NHSE: Clinical Commissioning Policy for the use of therapeutic immunoglobulin (Ig) England (2024) NHSE: Clinical commissioning policy: Human normal immunoglobulin for preventative treatment of idiopathic systemic capillary leak syndrome following an acute episode (adults) [2270] |
|
Links
- Biosimilars policy statement
- HPA: Guidelines on managing rabies post-exposure prophylaxis
- Immunoglobulin handbook (HPA)
- Lancashire and South Cumbria Infant Feeding Network - Diagnosis and Management of Milk Allergy and Intolerance Guideline
- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NHSE: Clinical Commissioning Policy for the use of therapeutic immunoglobulin (Ig) England (2024)
- NHSE: Clinical commissioning policy: Human normal immunoglobulin for preventative treatment of idiopathic systemic capillary leak syndrome following an acute episode (adults) [2270]
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people